Patrick Skerrett is the Editor of First Opinion for STAT, a leading health and medicine news outlet. With a focus on opinion pieces, Patrick covers a wide range of topics in healthcare, including drug development, global health, mental health, and the impact of technology on healthcare.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Patrick's coverage primarily focuses on the health sector, particularly drug development and clinical research. He frequently cites data and government announcements, indicating a reliance on factual information from reliable sources.
Given Patrick's emphasis on legal policy regulation in his articles, he may be interested in commentary from experts who can provide insights into regulatory changes impacting drug development or clinical research. Additionally, given the frequent citations of data in his articles, pitches with strong statistical support or access to relevant datasets could be compelling for him.
While there is no specific geographic focus mentioned for Patrick, it might still be beneficial to offer insights that are globally applicable due to the nature of healthcare policies and drug development being broadly significant across different regions.
This information evolves through artificial intelligence and human feedback. Improve this profile .
It will take some doing to make psychedelic therapies ready for prime time, and it will be essential to develop them with psychoactive states lasting less than four hours.
By: Srinivas Akkaraju, Patrick Skerrett, Aleks Engel, Brian Finrow
"All models are wrong," as George Box once mischievously said, "but some are useful." We believe this is one of the useful ones.
Before retiring as STAT's founding First Opinion editor, Pat Skerrett sat down with @thekibosch, who has taken the reins of the platform. They chatted about hopes for the section, editorial pet peeves, and the vampire bats of Costa Rica.
By: Patrick Skerrett, Noura Abul-Husn
This rapid growth in genetic testing has created what some might see as a big problem and others might see as an opportunity.
By: Patrick Skerrett
By Patrick Skerrett April 6, 2024 STAT now publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues.
By: Patrick Skerrett
I have suffered with depression since I was a child. There's a reason there's a black box warning on every one of the SSRIs.
By: Patrick Skerrett
By Patrick Skerrett April 20, 2024 STAT publishes selected Letters to the Editor received in response to First Opinion essays to encourage robust, good-faith discussion about difficult issues.
By: Patrick Skerrett
I am moved by this article on Duchenne muscular dystrophy. We have made dramatic advances with genome sequencing for very rare diseases and must continue on this path to improve patient outcomes and quality of life for kids like Charlie. Let's keep pushing until we crack the code. I strongly urge the FDA to use the accelerated approval program for new treatments. We may also learn more by using AI in healthcare. It takes great minds with a lot of heart to find a cure for diseases like Duchenne. Thank you!
By: Patrick Skerrett
Financial strain is created by inequitable health financing structures that overpay private academic medical centers at the expense of safety net hospitals.
By Patrick Skerrett May 11, 2024 To encourage robust, good-faith discussion about difficult issues, STAT publishes selected Letters to the Editor received in response to First Opinion essays.
(833) 317-6278 
